Christopher Flowers, MD, Assistant Professor of Hematology and Oncology at Emory's Winship Cancer Institute is the first recipient of the American Society of Hematology Amos Faculty Development Award. The award is a joint initiative between ASH and the Robert Woods Johnson Foundation's Harold Amos Medical Faculty Development Program. The goal of the joint initiative is to increase the number of minority investigators who have academic and research appointments within the field of hematology.
In order to quality, applicants must have completed their formal clinical training and must commit to working in basic science research for four consecutive years. In addition, applicants must be committed to improving the status of the underserved and decreasing health disparities. For having earned the ASH-AMFDP Award, Dr. Flowers will receive a four-year complimentary ASH membership, which includes all expenses paid annual meeting attendance each year. In addition, Dr. Flowers will receive an annual stipend of $75,000 and an annual grant of $29,139 each for four years.
"We are delighted and very proud that Dr. Flowers has earned this important award," said Paul Doetsch, PhD, Interim Director of the Emory Winship Cancer Institute. "Dr. Flowers is an exceptional scholar and certainly deserving of this award. His work will significantly advance the body of knowledge in cancer research, treatment and care."
Dr. Flowers' areas of research interest include oncology informatics, clinical and translational research and cancer outcomes research. In addition, Dr. Flowers is Adjunct Assistant Professor at the School of Industrial and Systems Engineering at the Georgia Institute of Technology. He is also the Director of the Lymphoma Program at Emory and a member of the Emory Stem Cell and Bone Marrow Transplant Team.
His current research projects span three areas: translational research clinical trials in non-Hodgkin lymphoma; oncology informatics projects developing an information infrastructure to support lymphoma outcomes research; and medical decision analysis and cost-effectiveness analysis aimed at developing strategies to individualize cancer care for patients.
"The ASH-AMFDP Award provides the protected time and resources to extend my focus on developing curative treatment strategies for patients with lymphoma. I am thrilled to have received this award," said Dr. Flowers.